Pharmaceutical Third-Party Logistics Market Size & Growth Forecast 2026–2035, By Segments (Temperature, Service, Product, Therapeutic Area, Manufacturer Size), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Pharmaceutical Third-Party Logistics Market size was over USD 145.88 Billion in 2025 and is likely to grow at a 9.1% CAGR between 2026 and 2035, reaching USD 348.53 Billion by 2035. The industry revenue for 2026 is calculated at USD 157.44 billion.
Get more details on this report
Request Free Sample ReportPharmaceutical Third-Party Logistics Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for a 40.60% share in 2025, driven by advanced supply chains, outsourcing adoption, and demand for specialized logistics services.
- Asia Pacific is projected to expand at a 10.28% CAGR, fueled by pharmaceutical growth, outsourced logistics demand, and expanding distribution networks.
Segment Momentum
- Ambient accounted for 50.88% of the market in 2025 because many pharmaceuticals can be stored and transported without cold-chain infrastructure, enabling efficient, high-volume distribution with lower operational complexity.
- DSCSA and Serialization Services are the fastest-growing segment as pharmaceutical companies increasingly require advanced traceability, product verification, and compliance-focused data management across distribution networks.
Market Expansion Drivers
- Growing demand for temperature-sensitive biologics accelerating cold chain logistics investments.
- Increasing pharmaceutical outsourcing strategies driving reliance on specialized 3PL service providers.
- Integration of AI-enabled monitoring and predictive analytics improving pharmaceutical supply chain efficiency.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Major companies in the pharmaceutical third-party logistics market include Cencora Corporation (United States), McKesson Corporation (United States), Cardinal Health, Inc. (United States), Kuehne + Nagel International AG (Switzerland), DB Schenker (Germany), CEVA Logistics AG (Switzerland), Thermo Fisher Scientific Inc. (United States), EVERSANA Company (United States), Kerry Logistics Network Limited (Hong Kong), Knipper Health, Inc. (United States).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
Rising volumes of biologics, vaccines, and other temperature-sensitive therapies are reshaping service requirements in the pharmaceutical third-party logistics market, as manufacturers and distributors need tighter thermal control from storage through last-mile delivery. This is pushing logistics providers to expand validated cold storage capacity, invest in refrigerated transport assets, and deploy continuous temperature monitoring systems that reduce excursion risk and support product integrity. As more high-value therapies require narrow handling tolerances, buyers are favoring partners with proven cold chain compliance capabilities, supporting market development around specialized infrastructure rather than conventional pharmaceutical distribution.
Increasing pharmaceutical outsourcing strategies driving reliance on specialized 3PL service providers
As pharmaceutical companies continue to externalize non-core functions, logistics operations are increasingly being transferred to providers that can manage distribution complexity, regulatory documentation, inventory visibility, and multi-region delivery requirements under a single service model. In the pharmaceutical third-party logistics market, This transition is influencing market adoption by moving demand away from in-house networks toward specialized 3PL partners with established quality systems and healthcare-specific operating expertise. The practical effect is a deeper role for outsourced providers in day-to-day supply chain execution, especially where manufacturers want to reduce fixed logistics costs while maintaining service reliability for sensitive and time-critical products.
Integration of AI-enabled monitoring and predictive analytics improving pharmaceutical supply chain efficiency
The use of AI-enabled monitoring and predictive analytics is making the pharmaceutical third-party logistics market more responsive by improving shipment visibility, anticipating delays, and identifying handling risks before they disrupt product flow. Providers are using these tools to optimize routing, monitor environmental conditions in real time, and predict inventory or transport bottlenecks that could affect product availability or compliance performance. This is contributing to market size growth by making specialized logistics services more dependable and data-driven, which is especially valuable for pharmaceutical customers managing strict delivery windows, serialized products, and regulated cold chain operations.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Growing demand for temperature-sensitive biologics accelerating cold chain logistics investments | 2.00% | High | North America, Asia Pacific | High | Near Term |
| Increasing pharmaceutical outsourcing strategies driving reliance on specialized 3PL service providers | 1.70% | Moderate | Europe, North America | High | Mid Term |
| Integration of AI-enabled monitoring and predictive analytics improving pharmaceutical supply chain efficiency | 1.40% | High | Asia Pacific, North America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the leading regional position in 2025, accounting for a 40.60% share of the pharmaceutical third-party logistics market. Its leadership is underpinned by the region’s mature pharmaceutical supply chain infrastructure, high outsourcing penetration among drug manufacturers, and strict handling requirements for temperature-sensitive and high-value products. In practice, this supports steady demand for specialized warehousing, cold-chain transportation, inventory visibility, and regulatory-compliant distribution services, particularly as pharmaceutical companies rely on logistics partners to manage service consistency and reduce complexity across broad healthcare networks.
Asia Pacific is projected to expand at a 10.28% CAGR over the forecast period in the pharmaceutical third-party logistics market, driven by the ongoing expansion of pharmaceutical manufacturing and distribution activity across the region. Growth is being accelerated by rising reliance on outsourced logistics to handle increasingly complex product flows, especially where scale-up in production and broader geographic reach require more structured transportation, storage, and delivery coordination. As supply chains become more organized and pharmaceutical volumes move across diverse domestic and cross-border channels, demand for capable third-party logistics providers continues to build.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants/Startups i Scale Low Medium High | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Supply NetworksGermany emphasizes pharmaceutical logistics solutions that ensure product integrity, traceability, and efficient cross-border distribution. The country's advanced healthcare manufacturing ecosystem supports investment in highly controlled logistics operations.
France 🇫🇷
Regulated Distribution ExcellenceFrance relies on specialized pharmaceutical logistics providers to maintain regulatory compliance, secure transportation, and product integrity across healthcare supply chains. The market continues emphasizing traceable logistics solutions for temperature-sensitive medicines.
Italy 🇮🇹
Healthcare Supply CoordinationItaly enhances pharmaceutical third-party logistics through improved warehousing, distribution efficiency, and cold chain management supporting hospitals and pharmacies. Italian logistics providers increasingly focus on dependable nationwide delivery for sensitive pharmaceutical products.
Japan 🇯🇵
Reliable Cold Chain OperationsJapan prioritizes pharmaceutical third-party logistics services that maintain strict temperature control and timely delivery for sensitive healthcare products. Japanese logistics providers continue strengthening operational reliability through automation and quality assurance practices.
South Korea 🇰🇷
Biopharma Logistics ExpansionSouth Korea strengthens pharmaceutical third-party logistics capabilities to support expanding biopharmaceutical manufacturing and healthcare distribution requirements. Investment in cold chain infrastructure and digital tracking enhances supply chain efficiency throughout the country.
United States 🇺🇸
Integrated Healthcare DistributionThe U.S. pharmaceutical third-party logistics market focuses on temperature-controlled distribution, inventory visibility, and regulatory compliance across complex healthcare supply chains. Logistics providers continue expanding specialized services that support biologics and specialty pharmaceuticals.
Segment Leadership and Growth Trends
Pharmaceutical Third-Party Logistics Market Share (%), Temperature, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAmbient held a 50.88% share of the pharmaceutical third-party logistics market in 2025, reflecting its role as the operational backbone for a broad range of drug distribution needs. This segment maintains leadership because many pharmaceutical products can be moved and stored without active cold-chain intervention, allowing logistics providers to serve higher shipment volumes with simpler infrastructure, wider warehouse compatibility, and lower handling complexity. In the pharmaceutical third-party logistics market, that practicality supports consistent use across routine distribution networks and keeps Ambient at the center of day-to-day fulfillment activity.
Refrigerated is emerging as the fastest-growing segment in the pharmaceutical third-party logistics market as temperature-sensitive products require tighter transport control and more specialized handling. Its momentum is being influenced by the growing need to preserve product stability across storage and transit, which raises demand for validated cold-chain capabilities that standard ambient networks cannot provide. Compared with alternatives, Refrigerated logistics is gaining faster because it addresses stricter operational requirements and supports pharmaceutical shipments where temperature deviation carries a higher risk of product loss or compliance issues.
Service Segment Analysis: Storage and Shipping (Largest Segment) vs DSCSA and Serialization Services (Fastest-Growing Segment)
By 2025, Storage and Shipping accounted for a 45.41% share of the pharmaceutical third-party logistics market, underscoring its central role in the physical movement and holding of pharmaceutical products. The segment leads because every supply chain transaction ultimately depends on dependable warehousing and transport execution, making these services the core volume drivers for third-party logistics providers. In the pharmaceutical third-party logistics market, this foundational function sustains demand across manufacturers, distributors, and healthcare channels, reinforcing the segment’s leading share through routine and recurring operational reliance.
DSCSA and Serialization Services represent the fastest-growing area of the pharmaceutical third-party logistics market as supply chains require stronger traceability, product verification, and compliance-linked data handling. Growth is accelerating here because these services help companies manage increasingly detailed serialization workflows and meet regulatory documentation requirements that extend beyond basic storage or freight execution. Relative to traditional service categories, DSCSA and Serialization Services are gaining momentum faster because they respond directly to rising compliance complexity and the need for more integrated visibility across pharmaceutical distribution.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Temperature | Ambient, Refrigerated, Frozen, Ultra-frozen/Deep-Frozen, Cryogenic | Ambient | Refrigerated |
| Service | Storage and Shipping, Order-to-cash, Title Model, DSCSA and Serialization Services, Pharmaceutical Sampling, Others | Storage and Shipping | DSCSA and Serialization Services |
| Product | Branded, Generic, Biosimilar, Vaccine, Cell Therapy, Gene Therapy, Others | Branded | Cell Therapy |
| Therapeutic Area | Oncology, Cardiovascular Diseases, Infectious Diseases, Neurology, Diabetes, Nephrology, Rheumatology, Allergy/Asthma, Gastroenterology, Ophthalmology, Others | Oncology | Neurology |
| Manufacturer Size | Large, Medium, Small | Large | Medium |
Competitive Landscape and Market Positioning
1. Cencora Corporation (United States)
2. McKesson Corporation (United States)
3. Cardinal Health Inc. (United States)
4. Kuehne + Nagel International AG (Switzerland)
5. DB Schenker (Germany)
6. CEVA Logistics AG (Switzerland)
7. Thermo Fisher Scientific Inc. (United States)
8. EVERSANA Company (United States)
9. Kerry Logistics Network Limited (Hong Kong)
10. Knipper Health Inc. (United States)
The pharmaceutical third-party logistics market is being transformed through the integration of temperature-controlled supply chains, real-time tracking systems, and automated inventory management technologies. Service providers are emphasizing regulatory compliance and efficient distribution frameworks to support the safe handling of sensitive pharmaceutical products. Growing complexity in global healthcare logistics is further accelerating digital transformation within the market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| EVERSANA | Apr-25 | EVERSANA expanded its distribution footprint with a new 358,000-square-foot facility in Memphis. The site incorporates cold-chain capabilities and AI-driven automation to enhance temperature-controlled logistics, supply chain efficiency, and advanced operational handling for complex pharmaceutical products. |
| DSV | Sep-24 | DSV signed a definitive agreement to acquire DB Schenker for approximately EUR 14.3 billion. This transformative acquisition, completed in April 2025, integrates DB Schenker’s global logistics network and infrastructure into DSV, significantly scaling the company's contract logistics capabilities and market reach. |
| CEVA Logistics | Sep-24 | CEVA Logistics finalized an agreement to assume freight management responsibilities from CMA CGM. This operational realignment is designed to optimize business growth for CEVA while allowing CMA CGM to refocus on its core shipping operations, streamlining the service delivery model for clients. |
| EVERSANA | May-23 | EVERSANA extended its strategic partnership with Yaral Pharma to support the commercialization of the latter's pain and endocrinology portfolio in the U.S. The scope of the engagement includes comprehensive 3PL and operational support, facilitating seamless market access and distribution for Yaral Pharma's product line. |
| DHL Group | Apr-25 | DHL Group acquired Cryopdp, a provider specialized in temperature-controlled logistics for biopharmaceuticals and clinical trials. This acquisition bolsters DHL’s specialized service offerings, strengthening its ability to manage high-stakes, time-sensitive shipments within the life sciences and healthcare vertical. |
| DHL Group | Mar-25 | DHL Group announced a strategic initiative to double its Life Science and Healthcare revenue to approximately EUR 10 billion by 2030. The growth plan involves substantial investment in expanding its network of GDP-compliant facilities globally to meet rising demand for specialized pharmaceutical distribution services. |
| UPS | Jan-25 | UPS completed the acquisition of Frigo-Trans and BPL to enhance its temperature-controlled logistics capabilities in Europe. These additions strengthen UPS's infrastructure for handling sensitive healthcare products, providing increased capacity and specialized expertise to support its regional pharmaceutical supply chain operations. |
| DHL Supply Chain | Jan-25 | DHL Supply Chain signed an agreement to acquire Inmar Supply Chain Solutions. This acquisition significantly scales DHL's pharmaceutical 3PL presence in North America, integrating Inmar’s logistics footprint to improve service coverage and operational capacity for healthcare customers. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Pharmaceutical Third-Party Logistics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Pharmaceutical Third-Party Logistics Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the pharmaceutical third-party logistics market?
How is the pharmaceutical third-party logistics industry size expected to evolve during the forecast period?
How are biologics driving investment priorities in pharmaceutical third-party logistics?
How is pharmaceutical outsourcing reshaping reliance on 3PL providers?
Why is Ambient the leading temperature segment in the pharmaceutical third-party logistics market?
Which service segment is expanding the fastest in the pharmaceutical third-party logistics market?
What factors support North America’s leadership in pharmaceutical third-party logistics?
Why is Asia Pacific becoming a key growth region for pharmaceutical third-party logistics?
Which companies are driving growth in the pharmaceutical third-party logistics landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization